Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).

The restricted stock units shall vest over a period of 24 months, with 25,000 shares vesting on September 1, 2027 and the remaining shares vesting quarterly over the subsequent 12 months, subject to Cheng’s continuous service with Cardlytics through each vesting date. The restricted stock units are subject to the terms and conditions of the 2022 Inducement Plan.

About Cardlytics
Cardlytics (NASDAQ: CDLX) is a purchase intelligence platform that transforms $5.8 trillion in annual transaction data into smarter growth strategies for brands and more rewarding experiences for consumers. With visibility into one of every two card-based transactions in the U.S. and U.K., Cardlytics delivers the scale and depth of purchase intelligence that no other platform can match. Brands activate that intelligence through personalized, card-linked offers that drive measurable results across leading banking and commerce platforms worldwide. Since 2008, Cardlytics has delivered $1.2 billion in rewards to consumers. Learn more at www.cardlytics.com or follow us on LinkedIn.